Trelegy ellipta and Pregabalin drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Trelegy ellipta and Pregabalin. Common interactions include tinnitus among females and asthma among males.
The phase IV clinical study analyzes what interactions people who take Trelegy ellipta and Pregabalin have. It is created by eHealthMe based on reports of 70 people who take Trelegy ellipta and Pregabalin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
70 people who take Trelegy ellipta and Pregabalin together, and have interactions are studied.
What is Trelegy ellipta?
Trelegy ellipta has active ingredients of fluticasone furoate; umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 16,526 Trelegy ellipta users for its effectiveness, alternative drugs and more.
What is Pregabalin?
Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 53,090 Pregabalin users for its effectiveness, alternative drugs and more.
Number of Trelegy ellipta and Pregabalin reports submitted per year:
Common Trelegy Ellipta and Pregabalin drug interactions by gender *:
- Uterine leiomyoma
- Lower respiratory tract infection
- Confusional state
- Micturition urgency
- Oedema peripheral
- Bone density decreased
- Emotional distress
- Respiratory failure
- Alanine aminotransferase increased
- Analgesic drug level decreased
Common Trelegy Ellipta and Pregabalin drug interactions by age *:
- Decreased activity
- Anaphylactic reaction
- Diverticulum intestinal
- Chest discomfort
- Gastric disorder
- Multiple fractures
- Productive cough
- Haemoglobin decreased
Common conditions people have *:
- Psoriasis (immune-mediated disease that affects the skin): 12 people, 17.14%
- Itching: 11 people, 15.71%
- Dizziness: 11 people, 15.71%
- Abdominal Distension: 11 people, 15.71%
- Asthma: 8 people, 11.43%
- Pain: 7 people, 10.00%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 5.71%
- Bipolar Disorder (mood disorder): 4 people, 5.71%
* Approximation only. Some reports may have incomplete information.
Do you take Trelegy ellipta and Pregabalin?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
Alternative drugs to, pros and cons of the 2 drugs:
- Trelegy ellipta (16,526 reports)
- Pregabalin (53,090 reports)
Browse all drug interactions of Trelegy ellipta and Pregabalin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Trelegy ellipta side effects:
- Breathing difficulty: 2,247 reports
- Drug ineffective: 1,452 reports
- Death: 1,408 reports
- Cough: 894 reports
- Pneumonia: 824 reports
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe): 634 reports
- Hoarseness or changing voice: 490 reports
- Chest pain: 427 reports
- Asthma: 424 reports
Browse all side effects of Trelegy ellipta:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Pregabalin side effects:
- Drug ineffective: 5,450 reports
- Fatigue (feeling of tiredness): 3,839 reports
- Pain: 3,486 reports
- Dizziness: 2,924 reports
- Breathing difficulty: 2,905 reports
- Headache (pain in head): 2,703 reports
- Weakness: 2,456 reports
- Nausea and vomiting: 2,282 reports
Browse all side effects of Pregabalin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Trelegy ellipta interactions:
- Trelegy ellipta and Prednisone: 772 reports
- Trelegy ellipta and Albuterol: 749 reports
- Trelegy ellipta and Aspirin: 617 reports
- Trelegy ellipta and Omeprazole: 570 reports
- Trelegy ellipta and Albuterol sulfate: 548 reports
- Trelegy ellipta and Vitamin d: 531 reports
- Trelegy ellipta and Breo ellipta: 518 reports
- Trelegy ellipta and Gabapentin: 514 reports
- Trelegy ellipta and Diphen: 454 reports
- Trelegy ellipta and Hydramine: 453 reports
Browse all interactions between Trelegy ellipta and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Pregabalin interactions:
- Pregabalin and Pantoprazole: 5,782 reports
- Pregabalin and Omeprazole: 4,677 reports
- Pregabalin and Prednisone: 4,561 reports
- Pregabalin and Tramadol: 4,329 reports
- Pregabalin and Morphine: 4,247 reports
- Pregabalin and Paracetamol: 4,231 reports
- Pregabalin and Metformin: 4,140 reports
- Pregabalin and Furosemide: 4,135 reports
- Pregabalin and Aspirin: 3,961 reports
- Pregabalin and Amlodipine: 3,578 reports
Browse all interactions between Pregabalin and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on fluticasone furoate; umeclidinium bromide; vilanterol trifenatate and pregabalin (the active ingredients of Trelegy ellipta and Pregabalin, respectively), and Trelegy ellipta and Pregabalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Trelegy ellipta and Pregabalin.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xanax and Bone Density Decreased - 5 seconds ago
- Tumor and drugs of ingredients of amlodipine besylate - 10 seconds ago
- Estrone and Muscle Aches - 13 seconds ago
- Remicade and Mitral Valve Stenosis - 20 seconds ago
- Lovenox and Bell'S Palsy - 23 seconds ago
- Plavix vs. Cordarone - 27 seconds ago
- Lithium Citrate and Renal Failure Chronic Aggravated - 27 seconds ago
- Tachypnea and drugs of ingredients of allopurinol - 28 seconds ago
- Cardiomyopathy and drugs of ingredients of lansoprazole - 29 seconds ago
- Lunesta and Pancreatitis - 30 seconds ago